WORLD HEALTH MONITOR live health, science & markets
Alerts · coming soon
Today for clinicians
–
!Safety alerts
loading…
–
High-impact studies
loading…
–
▲Practice deadlines
loading…
–
Wastewater
loading…
Global health map
Daily brief
Loading…
Health news
headlines · tap to read at source
Loading…
Practice-changing evidence
study · design · AI summary
Loading…
Safety & supply
most urgent first
Loading…
New approvals & launches
last 30 days on a timeline
Loading…
Practice & payment
deadlines · Federal Register
Loading…
Public health
alerts · wastewater by state
Loading…
Health cyber
devices · data breaches · CISA, HHS
Loading…
Watch & learn
short videos from trusted channels
Loading…
Biotech
–
Catalysts in 90 days
loading…
–
Phase 3 programs
loading…
–
Deals & funding
loading…
–
Next exclusivity loss
loading…
Where the activity is, by disease
last 90 days · catalysts: next 90 days · tap a row to switch disease
Loading…
Competitive landscape
industry programs by phase · ClinicalTrials.gov, FDA
Loading…
Catalysts · next 90 days
FDA dates · readouts · congresses
Loading…
Deals & funding
SEC filings incl. Form D private raises
Loading…
Exclusivity runway
Orange & Purple Book · bars end at the earliest generic entry
Loading…
Regulatory & policy signals
FDA · EMA · CMS · Federal Register
Loading…
Where trials are recruiting
trial sites by city · ClinicalTrials.gov
Readout recaps
results posted · trials stopped · last 30 days
Loading…
Built from public sources (ClinicalTrials.gov, FDA, EMA, SEC EDGAR, Federal Register), updated daily · ✦ marks AI summaries, which may contain errors · for information only, not investment advice
Use ⌘/Ctrl + scroll (or pinch) to zoom · drag to move
Map loads when online
Loading countries…
Daily briefloading…
For you · health topics evidence-labeled · updated daily
New research = meta-analyses, systematic reviews, randomized trials and guidelines from the last 30 days (PubMed).
Trials = newly posted studies now recruiting (ClinicalTrials.gov). Approvals = FDA approvals in the last 30 days. Information only: talk to your doctor before changing anything.
Safety & supplyloading…
New approvalsloading…
Practice & paymentloading…
Public healthloading…
IPOsloading…
M&A & dealsloading…
Patents & exclusivityloading…
Competitor radarloading…
Regulatory signalsloading…
Watch & learnshort videos
Talent & operationsloading…
Clinical trial readoutsloading…
Understand this conditionloading…
Policy & pricingloading…
New literatureloading…
Regulatory feed loading…
Clinical trialsloading…
Catalyst calendarloading…
Market moversloading…
saved in this browser · health-care stocks we track
Ticker
Move
Trend
Why
Patents & IPOs loading…
Dates as listed by the FDA (Orange Book for small-molecule drugs, Purple Book for biologics).
"Generic possible from" is the later of the last listed patent and the last exclusivity. Patents can be challenged, extended or settled,
so generics or biosimilars may arrive earlier or later. Not investment advice.
Companies in pharma, biotech, medical devices, diagnostics,
life-science tools and health services (by SEC industry code) that registered to go public, from SEC EDGAR filings:
S-1/F-1 = filed, 424B4 final prospectus = priced, ticker listed = trading, RW = withdrawn. Not investment advice.
Company healthloading…
Health news loading…
Outbreaks & health policy loading…
My disease watchlist saved in this browser
Add the conditions you follow (up to 12); what is new for each shows below. Tap ✓ to remove one.
PROSmart alertsemail and phone alerts for PDUFA dates, readouts, rejection letters and patent challenges on the companies you followComing soon
Health cyber · devices, health data breaches loading…